Advanced search
Publication Cover
Journal of Chemotherapy Volume 28, 2016 - Issue 4
Submit an article Journal homepage
67
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Isn't it time to talk about antiretroviral stewardship?

Ian WoolleyMonash Infectious Diseases, Monash Health and Departments of Medicine and Infectious Diseases, Monash University, Clayton, VIC, AustraliaCorrespondence[email protected]
Pages 352-354 | Received 28 Oct 2014, Accepted 05 Feb 2015, Published online: 27 Jul 2016

References

  • Hontelez JAC , Lurie MN , Bärnighausen T , Bakker R , Baltussen R , Tanser F , et al. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Medicine. 2013;10:e1001534.
  • Passaes CP , Sáez-Cirión A . HIV cure research: advances and prospects. Virology. 2014;45(4–455):340–52.
  • Looke DF , Gottlieb T , Jones CA , Paterson DL . Gram-negative resistance: can we combat the coming of a new “Red Plague”? Med J Aust. 2013;198:243–4.
  • Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed June 30th, 2014)..
  • Available from: http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html (accessed June 30th, 2014)..
  • Available from: http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html (accessed June 30, 2014)..
  • Available from: http://www.ncbi.nlm.nih.gov/pubmed/ (access May 31st, 2014)..
  • Kim D , Ziebell R , Saduvala N , Kline R , Banez Ocfemia C , Prejean J , et al. Trends in Transmitted HIV-1 ARV drug resistance-associated mutations: 10 HIV Surveillance Areas, US, 2007-2010. 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013). Abstract 149, 2013. March 3–6, Atlanta.
  • Available from: http://www.who.int/mediacentre/factsheets/fs194/en/ (accessed May31st 2014)..
  • Jansson J , Wilson DP , Carr A , Petoumenos K , Boyd MA . Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV. AIDS. 2013;27:1245–51.
  • Bebenek K , Abbotts J , Wilson SH , Kunkel TA . Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. J Biol Chem. 1993;268:10324–34.
  • Sanders J , Pallotta A , Bauer S , Sekeres J , Davis R , Taege A , et al. Antimicrobial stewardship program to reduce antiretroviral medication errors in hospitalized patients with human immunodeficiency virus infection. Infect Control Hosp Epidemiol. 2014;35:272–7.
  • Traynor K . Antiretroviral stewardship program reduces drug errors. Am J Health Syst Pharm. 2013;70:1964–5.
  • Koenig LJ , Lyles C , Smith DK . Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: Lessons learned from trials and treatment studies. Am J Prev Med. 2013;44:S91–8.
  • Lehman D , Baeten JM , McCoy C , Weis J , Peterson D , Celum C , et al. PrEP exposure and the risk of low-frequency drug resistance. Conference on Retroviruses and Opportunistic Infections (CROI). Abstract 590LB, March 3–6, 2014, Boston 2014.
  • Davies O , Alexander H , Robinson N , Pace M , Brady M , Frater J , et al. Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy. Abstracts of the HIV Drug Therapy Glasgow Congress October 23-27, 2014. Journal of the International AIDS Society. 2014;17(Suppl 3):19731.
  • Available from: http://buytenofovir.org/ accessed June 30th 2014..
  • Available from: http://dvpharm.com/buy-viread-usa.html (accessed June 30th 2014)..
  • Revell AD , Wang D , Wood R , Morrow C , Tempelman H , Hamers RL , et al. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. J Antimicrob Chemother. 2013;68:1406–14.
  • Yu X , Weber IT , Harrison RW . Prediction of HIV drug resistance from genotype with encoded three-dimensional protein structure. BMC Genomics. 2014;15(Suppl 5):S1.
  • Gupta RK , Wainberg MA , Brun-Vezinet F , Gatell JM , Albert J , Sönnerborg A , et al. Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs. J Infect Dis. 2013;207(Suppl 2):S101–6.
  • Kim SJ , Toma HS . Antimicrobial Resistance and Ophthalmic Antibiotics1-Year Results of a Longitudinal Controlled Study of Patients Undergoing Intravitreal Injections. Arch Ophthalmol. 2011;129:1180–8.
  • Abdool Karim Q , Abdool Karim SS , Frohlich JA , Grobler AC , Baxter C , Mansoor LE , et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.
  • Trivedi KK , Pollack LA . The role of public health in antimicrobial stewardship in healthcare. Clin Infect Dis. 2014;59(Suppl 3):S101–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.